Expand INDV Menu
INDV MENU

INDV Latest Press Releases

-- December 22, 2025 --

Indivior Announces Inclusion in the S&P SmallCap 600 Index PRNewswire 7:00 AM

-- December 17, 2025 --

New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations PRNewswire 11:30 AM

-- December 5, 2025 --

CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PRNewswire 5:50 PM

-- November 20, 2025 --

Indivior Concludes Legacy U.S. Department of Justice Matter PRNewswire 4:01 PM

-- November 19, 2025 --

Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference PRNewswire 9:21 AM

-- November 3, 2025 --

Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine PRNewswire 8:00 AM

-- October 30, 2025 --

Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance PRNewswire 7:01 AM

-- October 28, 2025 --

Indivior to Participate in the Stifel 2025 Healthcare Conference PRNewswire 10:00 AM

-- October 16, 2025 --

Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th PRNewswire 4:05 PM

-- October 15, 2025 --

Clinical Evidence Supports Rapid SUBLOCADE Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment PRNewswire 8:03 AM

-- October 1, 2025 --

Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation PRNewswire 8:01 AM

-- August 20, 2025 --

Indivior to Participate in Upcoming Investor Events PRNewswire 12:00 PM
Market Data Delayed 15 Minutes